BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8778771)

  • 1. Carcinogen-derived biomarkers and lung cancer.
    Hecht SS
    Prev Med; 1996; 25(1):7-9. PubMed ID: 8778771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco smoke carcinogens and lung cancer.
    Hecht SS
    J Natl Cancer Inst; 1999 Jul; 91(14):1194-210. PubMed ID: 10413421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke.
    Hecht SS
    Tob Control; 2004 Mar; 13 Suppl 1(Suppl 1):i48-56. PubMed ID: 14985617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A relevant dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is extensively metabolized and rapidly absorbed in the canine tracheal mucosa.
    Gerde P; Muggenburg BA; Stephens T; Lewis JL; Pyon KH; Dahl AR
    Cancer Res; 1998 Apr; 58(7):1417-22. PubMed ID: 9537242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cigarette smoking and lung cancer-elucidating an enigma].
    Ciornea L; Miron L; Ghiorghiu S
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(1):49-53. PubMed ID: 12092158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke.
    Hecht SS; Carmella SG; Murphy SE; Akerkar S; Brunnemann KD; Hoffmann D
    N Engl J Med; 1993 Nov; 329(21):1543-6. PubMed ID: 8413477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
    Hecht SS
    IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention.
    Hecht SS
    Ann N Y Acad Sci; 1997 Dec; 833():91-111. PubMed ID: 9616743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen.
    Hecht SS
    Crit Rev Toxicol; 1996; 26(2):163-81. PubMed ID: 8688159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate.
    Hecht SS; Trushin N; Rigotty J; Carmella SG; Borukhova A; Akerkar S; Rivenson A
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):645-52. PubMed ID: 8824368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines.
    Hecht SS; Carmella SG; Foiles PG; Murphy SE
    Cancer Res; 1994 Apr; 54(7 Suppl):1912s-1917s. PubMed ID: 8137311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.
    Rivenson A; Hoffmann D; Prokopczyk B; Amin S; Hecht SS
    Cancer Res; 1988 Dec; 48(23):6912-7. PubMed ID: 3180100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer.
    Jin F; Thaiparambil J; Donepudi SR; Vantaku V; Piyarathna DWB; Maity S; Krishnapuram R; Putluri V; Gu F; Purwaha P; Bhowmik SK; Ambati CR; von Rundstedt FC; Roghmann F; Berg S; Noldus J; Rajapakshe K; Gödde D; Roth S; Störkel S; Degener S; Michailidis G; Kaipparettu BA; Karanam B; Terris MK; Kavuri SM; Lerner SP; Kheradmand F; Coarfa C; Sreekumar A; Lotan Y; El-Zein R; Putluri N
    Cancer Prev Res (Phila); 2017 Oct; 10(10):588-597. PubMed ID: 28851690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing carcinogen levels in cigarette smoke.
    Mirvish SS
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2170-1; author reply 2171-2. PubMed ID: 17932371
    [No Abstract]   [Full Text] [Related]  

  • 15. Placental transfer of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone instilled intratracheally in Syrian golden hamsters.
    Jorquera R; Castonguay A; Schuller HM
    Cancer Res; 1992 Jun; 52(12):3273-80. PubMed ID: 1596885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
    Carmella SG; Ye M; Upadhyaya P; Hecht SS
    Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
    Trushin N; Hecht SS
    Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer.
    Hecht SS; Carmella SG; Murphy SE; Foiles PG; Chung FL
    J Cell Biochem Suppl; 1993; 17F():27-35. PubMed ID: 8412204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.